在癌症进展中的自/副生长激素
Xi Zhang1, Vijay Pandey2, Vipul Bhardwaj2
1Shenzhen Bay Laboratory, Shenzhen, P R China.
Endocrine-related cancer
|October 25, 2023
概括
癌症中生长激素 (GH) 的额外垂体表达促进瘤的进展和对治疗的抗性. 向瘤衍生的GH提供了一种新的治疗策略,用于改善瘤学中患者生存结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 增长激素 (GH) 主要被称为垂体激素,调节生长和新陈代谢.
- 越来越多地认识到GH的异位表达,特别是在癌症中.
- 与瘤相关的GH表达与晚期癌症和较差的患者预后相关.
研究的目的:
- 研究外生长激素 (GH) 在癌症进展中的作用.
- 阐明瘤衍生GH在促进癌症特征中的功能机制.
- 评估瘤衍生GH作为瘤学中的潜在治疗点.
主要方法:
- 在各种类型的人类癌症中分析GH表达.
- 使用体外和体外模型研究瘤衍生的GH的功能后果.
- 评估由GH诱导的瘤信号通路和分泌体变化.
主要成果:
- GH在额外垂体部位表达,包括多种癌症类型 (例如乳腺,肝脏,前列腺).
- 来自瘤的GH促进癌细胞的增殖,存活,血管新生,上皮细胞转变为介质细胞,并通过自身/副细胞信号传递转移.
- GH激活致癌途径并增强致癌分泌体,从而促进治疗耐药性.
结论:
- 癌症中的额外垂体GH表达驱动瘤进展,独立于内分泌GH.
- 来自瘤的GH是先进的临床病理学参数和更差的生存结果的重要因素.
- 向额外垂体GH代表了瘤学中验证的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autocrine Signaling
48.1K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer
48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


